Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TCRTthis companyAlaunos Therapeutics, Inc.	$1.76	-1.47×	2.92×	1,258.64×	-1.18×	-81.2%	-27160.0%	-84500.0%	-83520.0%	-194.0%	-196.2%	-47.1%	0×	0.33×	0×	2.45×	0.0%	1	-860.38	1	C-
AIMAIM ImmunoTech Inc.	$0.16	-0.13×	-0.19×	20.78×	-0.45×	-2271.9%	-284.1%	-11961.4%	-15861.4%	142.7%	-313.6%	-619.7%	-0.5×	-0.31×	-12.96×	0.53×	0.0%	3	-51.36	2	C
IBOImpact BioMedical Inc.	$4.03	-1.33×	1.26×	497.66×	-1.27×	-100.4%	-1225.0%	-13343.8%	-36993.8%	-93.9%	-21.6%	-11.9%	0×	0×	-5.38×	0.35×	0.0%	4	2.31	2	C+
KTTAPasithea Therapeutics Corp.	$0.61	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
QNRXQuoin Pharmaceuticals, Ltd.	$3.86	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
Peer median	—	-0.89×	0.71×	10.39×	0.92×	965.7%	-142.0%	-5980.7%	-7930.7%	-65.4%	-73.7%	-115.2%	0×	1.37×	-2.69×	2.07×	0.0%	3	-6.13	2	—